禽卵黄抗体在生物武器高毒成分失活和特别危险感染中的应用

{"title":"禽卵黄抗体在生物武器高毒成分失活和特别危险感染中的应用","authors":"","doi":"10.35825/2587-5728-2022-6-2-137-151","DOIUrl":null,"url":null,"abstract":"Currently, Western pharmaceutical companies have mastered the production of licensed drugs based on transovarial chicken specific antibodies (IgY antibodies) intended for the treatment and prevention of infections caused by Helicobacter pylori, influenza virus and other pathogens. Of particular interest is the possibility of using IgY antibodies as an inexpensive specific antidote for emergency specific prevention of infections caused by pathogens of dangerous and especially dangerous infections. The purpose of this work is to summarize the results of studies that have shown a high therapeutic potential of transovarial specific immunoglobulins in the treatment and prevention of dangerous viral, bacterial infections and injuries by biological toxins – potential agents of biological weapons (BW). The advantage of using IgY technologies for passive immunization is a non-invasive method for obtaining antibodies, as well as a large amount of them – 20–30 g of immunoglobulins, which can be obtained from one laying hen per year. An important advantage of IgY over immunoglobulins derived from mammalian serum is that they do not interact with complement components, nor with rheumatoid factor, nor with Fc receptors of mammalian immunocompetent cells, which significantly reduces the manifestation of adverse reactions, in particular, antibody-dependent enhancement of infection (ADE). Experiments carried out in vivo and in vitro showed a high activity of IgY antibodies in suppressing the damaging effect of pathogens of especially dangerous infections and biological toxins. It is shown in the article, that the replacement of mammalian IgG with avian transovarial IgY allows obtaining commercially significant amounts of thermostable specific antibodies that do not cause ADE, and expands the possibilities of methods for specific prevention and treatment of lesions caused by viruses, bacteria, and toxins – potential agents of biological weapons","PeriodicalId":16578,"journal":{"name":"Journal of NBC Protection Corps","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Avian Yolk Antibodies in the Inactivation of Highly Toxic Components of Biological Weapons and Especially Dangerous Infections\",\"authors\":\"\",\"doi\":\"10.35825/2587-5728-2022-6-2-137-151\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Currently, Western pharmaceutical companies have mastered the production of licensed drugs based on transovarial chicken specific antibodies (IgY antibodies) intended for the treatment and prevention of infections caused by Helicobacter pylori, influenza virus and other pathogens. Of particular interest is the possibility of using IgY antibodies as an inexpensive specific antidote for emergency specific prevention of infections caused by pathogens of dangerous and especially dangerous infections. The purpose of this work is to summarize the results of studies that have shown a high therapeutic potential of transovarial specific immunoglobulins in the treatment and prevention of dangerous viral, bacterial infections and injuries by biological toxins – potential agents of biological weapons (BW). The advantage of using IgY technologies for passive immunization is a non-invasive method for obtaining antibodies, as well as a large amount of them – 20–30 g of immunoglobulins, which can be obtained from one laying hen per year. An important advantage of IgY over immunoglobulins derived from mammalian serum is that they do not interact with complement components, nor with rheumatoid factor, nor with Fc receptors of mammalian immunocompetent cells, which significantly reduces the manifestation of adverse reactions, in particular, antibody-dependent enhancement of infection (ADE). Experiments carried out in vivo and in vitro showed a high activity of IgY antibodies in suppressing the damaging effect of pathogens of especially dangerous infections and biological toxins. It is shown in the article, that the replacement of mammalian IgG with avian transovarial IgY allows obtaining commercially significant amounts of thermostable specific antibodies that do not cause ADE, and expands the possibilities of methods for specific prevention and treatment of lesions caused by viruses, bacteria, and toxins – potential agents of biological weapons\",\"PeriodicalId\":16578,\"journal\":{\"name\":\"Journal of NBC Protection Corps\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of NBC Protection Corps\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35825/2587-5728-2022-6-2-137-151\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of NBC Protection Corps","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35825/2587-5728-2022-6-2-137-151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目前,西方制药公司已经掌握了基于经卵巢鸡特异性抗体(IgY抗体)的许可药物的生产,用于治疗和预防幽门螺杆菌、流感病毒等病原体引起的感染。特别令人感兴趣的是,有可能使用IgY抗体作为一种廉价的特定解毒剂,用于紧急特定预防由危险和特别危险感染的病原体引起的感染。本工作的目的是总结研究结果,表明经卵巢特异性免疫球蛋白在治疗和预防危险的病毒,细菌感染和生物毒素-潜在的生物武器(BW)的伤害具有很高的治疗潜力。使用IgY技术进行被动免疫的优点是可以无创地获得抗体,而且获得的抗体量很大,每年可从一只蛋鸡身上获得20 - 30g的免疫球蛋白。IgY与来自哺乳动物血清的免疫球蛋白相比,一个重要的优势是它们不与补体成分、类风湿因子和哺乳动物免疫活性细胞的Fc受体相互作用,这大大减少了不良反应的表现,特别是抗体依赖性增强感染(ADE)。体内和体外实验表明,IgY抗体在抑制病原体特别是危险感染和生物毒素的破坏作用方面具有很高的活性。文章表明,用禽类经卵巢IgY替代哺乳动物IgG可以获得商业上大量的耐热特异性抗体,这些抗体不会引起ADE,并扩大了特定预防和治疗由病毒、细菌和毒素(潜在的生物武器制剂)引起的病变的方法的可能性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Use of Avian Yolk Antibodies in the Inactivation of Highly Toxic Components of Biological Weapons and Especially Dangerous Infections
Currently, Western pharmaceutical companies have mastered the production of licensed drugs based on transovarial chicken specific antibodies (IgY antibodies) intended for the treatment and prevention of infections caused by Helicobacter pylori, influenza virus and other pathogens. Of particular interest is the possibility of using IgY antibodies as an inexpensive specific antidote for emergency specific prevention of infections caused by pathogens of dangerous and especially dangerous infections. The purpose of this work is to summarize the results of studies that have shown a high therapeutic potential of transovarial specific immunoglobulins in the treatment and prevention of dangerous viral, bacterial infections and injuries by biological toxins – potential agents of biological weapons (BW). The advantage of using IgY technologies for passive immunization is a non-invasive method for obtaining antibodies, as well as a large amount of them – 20–30 g of immunoglobulins, which can be obtained from one laying hen per year. An important advantage of IgY over immunoglobulins derived from mammalian serum is that they do not interact with complement components, nor with rheumatoid factor, nor with Fc receptors of mammalian immunocompetent cells, which significantly reduces the manifestation of adverse reactions, in particular, antibody-dependent enhancement of infection (ADE). Experiments carried out in vivo and in vitro showed a high activity of IgY antibodies in suppressing the damaging effect of pathogens of especially dangerous infections and biological toxins. It is shown in the article, that the replacement of mammalian IgG with avian transovarial IgY allows obtaining commercially significant amounts of thermostable specific antibodies that do not cause ADE, and expands the possibilities of methods for specific prevention and treatment of lesions caused by viruses, bacteria, and toxins – potential agents of biological weapons
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信